H295R cells as a model for steroidogenic disruption: A broader perspective using simultaneous chemical analysis of 7 key steroid hormones

Toxicology in Vitro

Volumn 26, Issue 2, 2012, Pages 343-350

  Nielsen, Frederik Knud ^a   Hansen, Cecilie Hurup ^a   Fey, Jennifer Anna ^a   Hansen, Martin ^a   Jacobsen, Naja Wessel ^a   Halling Sørensen, Bent ^a   Björklund, Erland ^a   Styrishave, Bjarne ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Endocrine disruption; GC MS MS; Genistein; Ketoconazole; Prochloraz; Solid phase extraction; Steroidogenesis

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROSTENEDIONE; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTRONE; GENISTEIN; KETOCONAZOLE; PRASTERONE; PREGNENOLONE; PROCHLORAZ; PROGESTERONE; STEROID 17,20 LYASE; STEROID 17ALPHA MONOOXYGENASE; STEROID HORMONE; TESTOSTERONE;

ADRENAL CORTEX CELL; ARTICLE; CHEMICAL ANALYSIS; CONTROLLED STUDY; H295R CELL; HORMONE SYNTHESIS; IMMUNOASSAY; MASS FRAGMENTOGRAPHY; QUANTITATIVE ANALYSIS; STEROIDOGENESIS;

BIOLOGICAL ASSAY; CELL LINE, TUMOR; CHROMATOGRAPHY, GAS; ENDOCRINE DISRUPTORS; GENISTEIN; GONADAL STEROID HORMONES; HUMANS; IMIDAZOLES; KETOCONAZOLE; STEROIDS; TANDEM MASS SPECTROMETRY;

EID: 84856432457     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.12.008     Document Type: Article

References (37)

1. Ayub M., Levell M.J. Inhibition of testicular 17[alpha]-hydroxylase and 17, 20-lyase but not 3[beta]-hydroxysteroid dehydrogenase-isomerase or 17[beta]-hydroxysteroid oxidoreductase by ketoconazole and other imidazole drugs. J. Steroid Biochem. 1987, 28(5):521-531.
2. Brass C., Galgiani J.N., Blaschke T.F., Defelice R., O'Reilly R.A., Stevens D.A. Disposition of ketoconazole, an oral antifungal, in humans. Antimicrob. Agents Chemother. 1982, 21(1):151-158.
3. Crain D.A., Janssen S.J., Edwards T.M., Heindel J., Ho S.M., Hunt P., Iguchi T., Juul A., McLachlan J.A., Schwartz J., Skakkebaek N., Soto A.M., Swan S., Walker C., Woodruff T.K., Woodruff T.J., Giudice L.C., Guillette L.J. Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timing. Fertil. Steril. 2008, 90(4):911-940.
4. Fanelli F., Belluomo I., Di Lallo V.D., Cuomo G., De Iasio R., Baccini M., Casadio E., Casetta B., Vicennati V., Gambineri A., Grossi G., Pasquali R., Pagotto U. Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: Comparison with current immunoassays and reference intervals in healthy adults. Steroids 2011, 76(3):244-253.
5. Gracia T., Hilscherova K., Jones P.D., Newsted J.L., Zhang X., Hecker M., Higley E.B., Sanderson J.T., Yu R.M., Wu R.S., Giesy J.P. The H295R system for evaluation of endocrine-disrupting effects. Ecotoxicol. Environ. Saf. 2006, 65(3):293-305.
6. Hansen, M., Jacobsen, N. W., Nielsen, F. K., Björklund, E., Styrishave, B., and Halling-Sørensen, B. Determination of steroid hormones in blood by GC-MS/MS. Anal. Bioanal. Chem. (in press), DOI: 10.1007/s00216-011-5038-8.
7. Hecker, M., Giesy, J. P., and Timm, G. E. Multi-Laboratory Validation of the H295R Steroidogenesis Assay to Identify Modulators of Testosterone and Estradiol Production, Prepared for U.S. Environmental Protection Agency (2008) available at: http://www.epa.gov/endo/pubs/h295r_validation_study_interim_report.pdf.1-2-2008.
8. Hecker M., Hollert H., Cooper R., Vinggaard A.M., Akahori Y., Murphy M., Nellemann C., Higley E., Newsted J., Laskey J., Buckalew A., Grund S., Maletz S., Giesy J., Timm G. The OECD validation program of the H295R steroidogenesis assay: Phase 3. Final inter-laboratory validation study. Environ. Sci. Pollut. Res. Int. 2011, 18(3):503-515.
9. Hecker M., Newsted J.L., Murphy M.B., Higley E.B., Jones P.D., Wu R., Giesy J.P. Human adrenocarcinoma (H295R) cells for rapid in vitro determination of effects on steroidogenesis: hormone production. Toxicol. Appl. Pharmacol. 2006, 217(1):114-124.
10. Higley E.B., Newsted J.L., Zhang X., Giesy J.P., Hecker M. Assessment of chemical effects on aromatase activity using the H295R cell line. Environ. Sci. Pollut. Res. Int. 2010, 17(5):1137-1148.
11. Hilscherova K., Jones P.D., Gracia T., Newsted J.L., Zhang X., Sanderson J.T., Yu R.M., Wu R.S., Giesy J.P. Assessment of the effects of chemicals on the expression of ten steroidogenic genes in the H295R cell line using real-time PCR. Toxicol. Sci. 2004, 81(1):78-89.
12. Ideyama Y., Kudoh M., Tanimoto K., Susaki Y., Nanya T., Nakahara T., Ishikawa H., Fujikura T., Akaza H., Shikama H. YM116, 2-(1H-Imidazol-4-ylmethyl)-9H-carbazole, decreases adrenal androgen synthesis by inhibiting C17-20 lyase activity in NCI-H295 human adrenocortical carcinoma cells. Japn. J. Pharmacol. 1999, 79(2):213-220.
13. Johansson M.K., Sanderson J.T., Lund B.O. Effects of 3-MeSO2-DDE and some CYP inhibitors on glucocorticoid steroidogenesis in the H295R human adrenocortical carcinoma cell line. Toxicol. in Vitro 2002, 16(2):113-121.
14. Kjærstad M.B., Taxvig C., Nellemann C., Vinggaard A.M., Andersen H.R. Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod. Toxicol. 2010, 30(4):573-582.
15. Le Bail J.C., Champavier Y., Chulia A.J., Habrioux G. Effects of phytoestrogens on aromatase, 3[beta] and 17[beta]-hydroxysteroid dehydrogenase activities and human breast cancer cells. Life Sci. 2000, 66(14):1281-1291.
16. Liu C., Zhang X., Chang H., Jones P., Wiseman S., Naile J., Hecker M., Giesy J.P., Zhou B. Effects of fluorotelomer alcohol 8:2 FTOH on steroidogenesis in H295R cells: targeting the cAMP signalling cascade. Toxicol. Appl. Pharmacol. 2010, 247(3):222-228.
17. Loose D.S., Kan P.B., Hirst M.A., Marcus R.A., Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J. Clin. Investig. 1983, 71(5):1495-1499.
18. Müller-Vieira U., Angotti M., Hartmann R.W. The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11B2 (aldosterone synthase) and CYP11B1 (steroid-11[beta]-hydroxylase) inhibitors. J. Steroid Biochem. Mol. Biol. 2005, 96(3-4):259-270.
19. O'Brien J., Wilson I., Orton T., Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 2000, 267(17):5421-5426.
20. OECD (2011), Test No. 456: H295R Steroidogenesis Assay, OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects, OECD Publishing. doi:. doi:10.1787/9789264122642-en.
21. Ohlsson Å., Cedergreen N., Oskarsson A., Ullerås E. Mixture effects of imidazole fungicides on cortisol and aldosterone secretion in human adrenocortical H295R cells. Toxicology 2010, 275(1-3):21-28.
22. Ohlsson Å., Ullerås E., Oskarsson A. A biphasic effect of the fungicide prochloraz on aldosterone, but not cortisol, secretion in human adrenal H295R cells-Underlying mechanisms. Toxicol. Lett. 2009, 191(2-3):174-180.
23. Ohno S., Shinoda S., Toyoshima S., Nakazawa H., Makino T., Nakajin S. Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells. J. Steroid Biochem. Mol. Biol. 2002, 80(3):355-363.
24. Penza M., Montani C., Romani A., Vignolini P., Ciana P., Maggi A., Pampaloni B., Caimi L., Di Lorenzo D. Genistein accumulates in body depots and is mobilized during fasting, reaching estrogenic levels in serum that counter the hormonal actions of estradiol and organochlorines. Toxicol. Sci. 2007, 97(2):299-307.
25. Pont A.L.L.A., Williams P.L., Loose D.S., Feldman D.A.V.I., Reitz R.E., Bochra C.H.A.R., Stevens D.A. Ketoconazole blocks adrenal steroid synthesis. Ann. Intern. Med. 1982, 97(3):370-372.
26. Sanderson J.T., Boerma J., Lansbergen G.W.A., van den Berg M. Induction and inhibition of aromatase (cyp19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. Toxicol. Appl. Pharmacol. 2002, 182(1):44-54.
27. Sanderson J.T., Hordijk J., Denison M.S., Springsteel M.F., Nantz M.H., van den Berg M. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol. Sci. 2004, 82(1):70-79.
28. Setchell K.D., Zimmer-Nechemias L., Cai J., Heubi J.E. Exposure of infants to phyto-oestrogens from soy-based infant formula. The Lancet 1997, 350(9070):23-27.
29. Stanczyk F.Z., Lee J.S., Santen R.J. Standardization of steroid hormone assays: why, how, and when?. Cancer Epidemiol. Biomarkers Prev. 2007, 16(9):1713-1719.
30. Taxvig C., Vinggaard A.M., Hass U., Axelstad M., Metzdorff S., Nellemann C. Endocrine-disrupting properties in vivo of widely used azole fungicides. Int. J. Androl. 2008, 31(2):170-177.
31. Toppari J., Larsen J.C., Christiansen P., Giwercman A., Grandjean P., Guillette L.J., Jegou B., Jensen T.K., Jouannet P., Keiding N., Leffers H., McLachlan J.A., Meyer O., Muller J., Rajpert-De M.E., Scheike T., Sharpe R., Sumpter J., Skakkebaek N.E. Male reproductive health and environmental xenoestrogens. Environ. Health Perspect. 1996, 104(Suppl. 4):741-803.
32. Trosken E.R., Scholz K., Lutz R.W., Volkel W., Zarn J.A., Lutz W.K. Comparative assessment of the inhibition of recombinant human CYP19 (aromatase) by azoles used in agriculture and as drugs for humans. Endocr. Res. 2004, 30(3):387-394.
33. Vinggaard A.M., Hass U., Dalgaard M., Andersen H.R., Bonefeld-Jorgensen E., Christiansen S., Laier P., Poulsen M.E. Prochloraz: an imidazole fungicide with multiple mechanisms of action. Int. J. Androl 2006, 29(1):186-192.
34. Vinggaard A.M., Hnida C., Breinholt V., Larsen J.C. Screening of selected pesticides for inhibition of CYP19 aromatase activity in vitro. Toxicol. in Vitro 2000, 14(3):227-234.
35. Vinggaard A.M., Nellemann C., Dalgaard M., Jorgensen E.B., Andersen H.R. Antiandrogenic effects in vitro and in vivo of the fungicide prochloraz. Toxicol. Sci. 2002, 69(2):344-353.
36. Wiseman H., Casey K., Bowey E.A., Duffy R., Davies M., Rowland I.R., Lloyd A.S., Murray A., Thompson R., Clarke D.B. Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am. J. Clin. Nutr. 2004, 80(3):692-699.
37. Zhang X., Yu R.M., Jones P.D., Lam G.K., Newsted J.L., Gracia T., Hecker M., Hilscherova K., Sanderson T., Wu R.S., Giesy J.P. Quantitative RT-PCR methods for evaluating toxicant-induced effects on steroidogenesis using the H295R cell line. Environ. Sci. Technol. 2005, 39(8):2777-2785.